Skip to main navigation
Home
  • fr 
  • en

Main navigation

  • Company
    • Company Profile
    • Management
    • Our History
    • Great Place To Work
  • Science
    • Scientific Approach
    • Innate Immunity & NK Cells
    • Antibody Formats
    • Publications
  • Products
    • Pipeline Overview
    • Clinical Trials
    • ------------------
    • LACUTAMAB
    • AVDORALIMAB
    • MONALIZUMAB
    • IPH5201
    • IPH5301
    • IPH6101
    • IPH62
    • ------------------
    • LUMOXITI
  • Partnering
  • Investors
    • Overview
    • News & Events
    • Financial & Regulatory Information
    • General Shareholders Meeting
    • Share Information
    • Investor Kit
    • Governance
  • Media
    • Media Hub
    • All Press Releases
    • Media Center
  • Careers

SEC Filing Details

  1. Home
  2. Investors
  3. F-1/A

SEC Filing Details

Document Details

Form
F-1/A
Filing Date
Oct 4, 2019
Document Date
Oct 4, 2019
Form Description
This filing is a pre-effective amendment to an F-1 filing
Filing Group
Registration Statements
Company
Innate Pharma
Issuer
Innate Pharma SA

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events
  • Financial and Regulatory Information
    • Financial Reports
    • SEC Filings
    • Financial Calendar
    • Number of Shares and Voting Rights
    • Articles of Association
    • Share Repurchase: liquidity agreement
    • Prospectus Related to Public Offering
    • Appraiser Reports
  • General Shareholders' Meeting
  • Share Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Kit
  • Corporate Governance
    • Committee Composition
    • Declaration by the Management Board and the Supervisory Board members
    • Corporate Transparency

Footer

  • Contact
  • Location
  • Legal Info
  • Terms of Use
  • Privacy Notice
  • Cookie Notice

Follow us

     

Stay in touch

  Subscribe to our newsletter

  Contact us
 

Location

117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

  +33 (0)4 30 30 30 30

  Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Innate Pharma